Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.
ALEXION PHARMACEUTICALS, INC. and ALEXION PHARMA INTERNATIONAL OPERATIONS LTD. |
SAMSUNG BIOEPIS CO. LTD. |
24-1829 |
May 20, 2024 |
U.S. Court of Appeals, Federal Circuit |
Patent Infringement (Fed. Qst.) |
Docket Report
This docket was last retrieved on May 20, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 4 Docketing Statement for the Appellants Alexion Pharmaceuticals, Inc. and Alexion Pharma International Operations Ltd.. Service: 05/20/2024 by email. [1005443] [24-1829] [Gerald Flattmann] [Entered: 05/20/2024 05:57 PM] |
Filing 3 Certificate of Interest for Appellants Alexion Pharmaceuticals, Inc. and Alexion Pharma International Operations Ltd.. Service: 05/20/2024 by email. [1005442] [24-1829] [Gerald Flattmann] [Entered: 05/20/2024 05:55 PM] |
Filing 2 Entry of Appearance for Gerald J. Flattmann Jr.; Andrew Cochran as counsel for Appellants Alexion Pharmaceuticals, Inc. and Alexion Pharma International Operations Ltd.. Service: 05/20/2024 by email. [1005441] [24-1829] [Gerald Flattmann] [Entered: 05/20/2024 05:53 PM] |
Filing 1 Appeal docketed. Received: 05/14/2024. [1005230] Entry of Appearance due 06/03/2024. Certificate of Interest is due on 06/03/2024. Docketing Statement due 06/03/2024. Appellant's brief is due 07/19/2024. [GWK] [Entered: 05/20/2024 11:44 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.